Venture Capital

New results from Maxus Mining's Quarry project reveal significant silver, lead, and zinc grades, bolstering BC's role in the critical metals supply chain.

With a unique Nasdaq listing plan and hydrogen-ready tech, Israeli firm Turbogen aims to disrupt the multi-billion dollar U.S. energy market.

As its CFO prepares for key investor meetings at the Roth Conference, Cerence AI aims to prove its dominance in the high-stakes race for the car of the future.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

A $2.3B construction firm opens a permanent office, betting its expertise can navigate a biotech real estate market ripe with both opportunity and risk.

With a €1.1M EU grant, Swedish innovator Polar Light is racing to commercialize its unique pyramidal MicroLEDs, aiming to redefine AR and automotive displays.

Inc. names Tiffany Whitlow to its Female Founders 500, validating Acclinate's model of making inclusive clinical research a profitable, high-growth venture.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

With a new film, 'One More Christmas,' Candace Cameron Bure solidifies her role as the architect of Great American Media's fast-growing holiday empire.

Red Bull Basement 2026 is open, challenging founders to build startups with AI, offering a $100k prize and a path from idea to the global stage.

With a new $60M fund and a former Lightspeed president, Boreal Ventures aims to turn great Canadian products into global commercial successes.

A new report projects explosive growth for Europe's solid-state battery sector, as automakers race to adopt safer, high-energy tech despite major hurdles.

After a failed reverse stock split, shipping firm OceanPal faces delisting. Can its ambitious AI subsidiary, SovereignAI, save it from the exchange?

A partnership between Biophytis and LynxKite leverages AI to fast-track therapies for sarcopenia and macular degeneration, backed by Singapore's RIE 2030 plan.

As it advances its brain cancer therapies, NeOnc Technologies hires a public company finance expert to steer its next growth phase and ensure fiscal rigor.

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

New research reveals a major disconnect: consumers, led by Gen Z, crave sustainable dining, but the foodservice industry is struggling to keep up.

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.